NUCLEUS RADIOPHARMA, INC.

Profile

Company Names

NUCLEUS RADIOPHARMA, INC.

Addresses

514 HIGH STREET, PALO ALTO, CA 94301

Phone Numbers

9804833788

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE

Year Incorporated:

2022

State Incorporated:

DELAWARE

Total Amount Raised:

$72,099,956.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2023-09-15 
$66,099,956.00 
$66,099,956.00 
$0.00 
Equity 
1
2022-10-04 
$6,000,000.00 
$6,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JUSTIN 
 
BUTLER 
DIRECTOR
SPELL INC.   |  LUCIRA HEALTH, INC.   |  BRIGHTINSIGHT HOLDINGS, INC.   |  BRIGHTINSIGHT, INC.   |  CELLARES CORP   |  RUNE LABS, INC.   |  NUCLEUS RADIOPHARMA, INC.
CHARLES 
 
CONROY 
EXECUTIVE OFFICER, DIRECTOR
NUCLEUS RADIOPHARMA, INC.
CHRIS 
 
MCDONALD 
DIRECTOR
GAZOO, INC.   |  NUCLEUS RADIOPHARMA, INC.   |  PHASE3.IO INC.
MANU 
 
NAIR 
DIRECTOR
NUCLEUS RADIOPHARMA, INC.
TYRELL 
 
RIVERS 
DIRECTOR
VIELA BIO, INC.   |  CORVIDIA THERAPEUTICS, INC.   |  PHASEBIO PHARMACEUTICALS INC   |  CERAPEDICS INC   |  NUCLEUS RADIOPHARMA, INC.   |  PATHOS AI, INC.
MICHAEL 
 
ROSSI 
DIRECTOR
IAGNOSIS, INC.   |  FIVE POINT HOLDINGS, LLC   |  BLUME HONEY WATER LLC   |  NUCLEUS RADIOPHARMA, INC.
NORMAN 
 
SHARPLESS 
DIRECTOR
G-ZERO THERAPEUTICS, INC.   |  G1 THERAPEUTICS, INC.   |  NUCLEUS RADIOPHARMA, INC.   |  INCYCLIX BIO, LLC
MARY KATE 
 
WOLD 
DIRECTOR
NUCLEUS RADIOPHARMA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-04-11
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-04 
2024-04-11
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2023-09-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#